These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8748967)

  • 21. Morphine withdrawal precipitated by specific mu, delta or kappa opioid receptor antagonists: a c-Fos protein study in the rat central nervous system.
    Le Guen S; Gestreau C; Besson JM
    Eur J Neurosci; 2003 Jun; 17(11):2425-37. PubMed ID: 12814374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal.
    Vandergriff J; Rasmussen K
    Neuropharmacology; 1999 Feb; 38(2):217-22. PubMed ID: 10218862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for a role of nitric oxide of the central nervous system in morphine abstinence syndrome.
    Bhargava HN; Thorat SN
    Pharmacology; 1996 Feb; 52(2):86-91. PubMed ID: 8851629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
    Zarrindast MR; Mohajeri S
    Eur J Pharmacol; 2006 Dec; 552(1-3):90-8. PubMed ID: 17049514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclic AMP-induced changes in the electroencephalogram and in behavior during morphine dependence and abstinence in the rat.
    Shahid Salles KS; Colasanti BK; Craig CR
    Sleep; 1979; 1(3):247-57. PubMed ID: 228372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopaminergic mechanisms in precipitated withdrawal in morphine-dependent rats.
    Ary M; Cox B; Lomax P
    J Pharmacol Exp Ther; 1977 Feb; 200(2):271-6. PubMed ID: 557107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in urination/defecation, auditory startle response, and startle-induced ultrasonic vocalizations in rats undergoing morphine withdrawal: similarities and differences between acute and chronic dependence.
    Kalinichev M; Holtzman SG
    J Pharmacol Exp Ther; 2003 Feb; 304(2):603-9. PubMed ID: 12538812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tolerance and withdrawal to chronic morphine treatment in the week-old rat pup.
    Barr GA; Wang S
    Eur J Pharmacol; 1992 Apr; 215(1):35-42. PubMed ID: 1516648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of histaminergic-noradrenergic axis in naloxone-induced withdrawal symptoms in mice.
    el Kadi AO; Sharif SI
    Pharmacol Biochem Behav; 1996 Sep; 55(1):49-54. PubMed ID: 8870037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuation of morphine withdrawal signs by a GABAB receptor agonist in the locus coeruleus of rats.
    Riahi E; Mirzaii-Dizgah I; Karimian SM; Sadeghipour HR; Dehpour AR
    Behav Brain Res; 2009 Jan; 196(1):11-4. PubMed ID: 18634832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of cholinergic agonists and antagonists on morphine-withdrawal syndrome.
    Hynes MD; Gianutsos G; Lal H
    Psychopharmacology (Berl); 1976 Sep; 49(2):191-5. PubMed ID: 825907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Wistar rats' individual sensitivity to the development of physical dependence on morphine.
    Sudakov SK; Konstantinopolsky MA; Surkova LA; Tyurina IV; Borisova EV
    Drug Alcohol Depend; 1991 Dec; 29(1):69-75. PubMed ID: 1797520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discriminative stimulus effects of naltrexone in the morphine-dependent rat.
    Gellert VF; Holtzman SG
    J Pharmacol Exp Ther; 1979 Dec; 211(3):596-605. PubMed ID: 574545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formalin-induced pain antagonizes the development of opiate dependence in the rat.
    Vaccarino AL; Couret LC
    Neurosci Lett; 1993 Oct; 161(2):195-8. PubMed ID: 8272266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opiate physical dependence and N-methyl-D-aspartate receptors.
    Noda Y; Nabeshima T
    Eur J Pharmacol; 2004 Oct; 500(1-3):121-8. PubMed ID: 15464026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modification of naloxone-induced withdrawal signs by dextromethorphan in morphine-dependent mice.
    Farzin D
    Eur J Pharmacol; 1999 Jul; 377(1):35-42. PubMed ID: 10448923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats.
    Aricioglu-Kartal F; Uzbay IT
    Life Sci; 1997; 61(18):1775-81. PubMed ID: 9365224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of testosterone on morphine withdrawal syndrome in rats.
    Nayebi AR; Rezazadeh H
    Asian J Androl; 2008 Sep; 10(5):765-9. PubMed ID: 18645680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspects of abstinence after morphine ingestion.
    Rönnbäck L; Eriksson PS; Zeuchner J; Rosengren L; Wronski A
    Pharmacol Biochem Behav; 1987 Sep; 28(1):87-93. PubMed ID: 3659110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide Mimetic of BDNF Loop 4 Blocks Behavioral Signs of Morphine Withdrawal Syndrome and Prevents the Increase in ΔFosB Level in the Striatum of Rats.
    Kolik LG; Konstantinopolsky MA; Nadorova AV; Kruglov SV; Antipova TA; Gudasheva TA; Seredenin SB
    Bull Exp Biol Med; 2020 Nov; 170(1):30-34. PubMed ID: 33222084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.